In particular, the differential effects of idelalisib and fostamatinib/ibrutinib on S1PR1 expression on CLL cells suggest that expression of the latter receptor is regulated by proximal BCR signals mediated by PI3Kδ but not distal BCR signals mediated by SYK and BTK. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.